Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
362 studies found for:    Open Studies | "Ovarian Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Ovarian Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer
Conditions: Ovarian Diseases;   Ovarian Neoplasms
Interventions: Other: Laboratory Tumor Marker Analysis;   Other: Transvaginal Ultrasound;   Other: Health Status Questionnaire
2 Recruiting Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer
Intervention: Drug: BIBF 1120
3 Unknown  Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer
Condition: Epithelial Ovarian Cancer
Intervention:
4 Unknown  Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199
Conditions: Fallopian Tube Cancer;   Hereditary Breast/Ovarian Cancer (brca1, brca2);   Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Interventions: Other: medical chart review;   Other: study of socioeconomic and demographic variables;   Procedure: disease screening;   Procedure: evaluation of cancer risk factors;   Procedure: genitourinary surgical procedure;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment
5 Recruiting Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: Malignant Ovarian Mixed Epithelial Tumor;   Ovarian Brenner Tumor;   Ovarian Carcinosarcoma;   Ovarian Clear Cell Cystadenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mucinous Cystadenocarcinoma;   Ovarian Serous Cystadenocarcinoma;   Ovarian Serous Surface Papillary Adenocarcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Undifferentiated Ovarian Carcinoma
Interventions: Drug: WEE1 Inhibitor MK-1775;   Drug: Gemcitabine Hydrochloride;   Other: Placebo;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
6 Recruiting Genetic Etiology in Premature Ovarian Insufficiency
Conditions: Primary Ovarian Insufficiency;   Genetic Predisposition to Disease
Intervention:
7 Not yet recruiting Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer
Intervention: Drug: everolimus and letrozole
8 Not yet recruiting Effect of Magnesium Supplementation on Polycystic Ovary Syndrome
Condition: Polycystic Ovary Syndrome
Interventions: Dietary Supplement: Magnesium Oxide;   Dietary Supplement: Placebo
9 Recruiting Surgical Complications Related to Primary or Interval Debulking in Ovarian Neoplasm
Condition: Stage IIIC Ovarian Cancer
Interventions: Procedure: Laparoscopy;   Procedure: Cytoreduction
10 Unknown  Perception and Attitude Toward Estrogen Therapy Among Surgically Menopausal Women
Conditions: Menopause, Premature;   Hysterectomy;   Ovariectomy;   Estrogen Replacement Therapy;   Attitude;   Perception
Intervention: Procedure: Hysterectomy and Bilateral salpingo-oophorectomy
11 Not yet recruiting A Study to Assess the Efficacy and Safety of Farletuzumab (MORAb 003) in Combination With Carboplatin Plus Paclitaxel or Carboplatin Plus Pegylated Liposomal Doxorubicin (PLD) in Subjects With Low CA125 Platinum-Sensitive Ovarian Cancer
Condition: Platinum-Sensitive Ovarian Cancer in First Relapse
Interventions: Drug: Farletuzumab;   Drug: Placebo
12 Unknown  Epidemiology of Ovarian Cancer in Taiwan
Condition: Ovarian Cancer
Intervention:
13 Recruiting Effect of Testosterone Treatment on Embryo Quality
Conditions: Primary Ovarian Insufficiency;   Female Infertility Due to Diminished Ovarian Reserve
Interventions: Drug: Testosterone cream (0.5mg per gram);   Dietary Supplement: DHEA;   Drug: Placebo
14 Unknown  Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction
Conditions: Hyperandrogenemia;   Obesity;   Polycystic Ovary Syndrome
Interventions: Drug: Hydrocortisone;   Drug: dexamethasone;   Drug: Cosyntropin;   Drug: r-hCG (Ovidrel)
15 Unknown  Stem Cell Therapy Combined Hormone Replacement Therapy in Patients With Premature Ovarian Failure
Condition: Premature Ovarian Failure,
Interventions: Biological: human umbilical cord mesenchymal stem cells;   Biological: hUCMSCs and hCBMNCs;   Biological: human cord blood mononuclear cells;   Drug: Hormone Replacement Therapy
16 Recruiting Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer
Conditions: Relapsed Epithelial Ovarian Cancer;   Relapsed Primary Peritoneal Cancer;   Relapsed Fallopian Tube Cancer
Interventions: Drug: Birinapant;   Drug: Conatumumab
17 Recruiting Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast Cancer
Conditions: Advanced Breast Carcinoma;   Advanced Ovarian Carcinoma
Intervention: Biological: ONT-10, Varlilumab combination
18 Recruiting Efficacy Study Comparing the Effect of Clomiphencitrate to an Antagonist Protocol
Conditions: Female Infertility;   Ovarian Insufficiency
Interventions: Drug: High Dose Clomiphencitrat;   Drug: Low Dose Clomiphencitrat;   Drug: High Dose Placebo;   Drug: Low dose Placebo
19 Unknown  Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy
Condition: Ovarian Carcinoma
Intervention: Drug: Cytophosphan, Celecoxib, Methotrexate
20 Recruiting Oxidative Stress and Bisphenol A (BPA) Impact With Polycystic Ovary Syndrome (PCOS)
Conditions: Oxidative Stress;   Endocrine Disrupting Chemicals;   Polycystic Ovary Syndrome
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years